These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 22098438

  • 1. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort.
    Craig WY, Ledue TB.
    Clin Chem Lab Med; 2011 Nov 18; 50(3):497-502. PubMed ID: 22098438
    [Abstract] [Full Text] [Related]

  • 2. The antinuclear antibody assay: developing criteria for reflexive anti-dsDNA antibody testing in a laboratory setting.
    Craig WY, Ledue TB.
    Clin Chem Lab Med; 2011 Jul 18; 49(7):1205-11. PubMed ID: 21612543
    [Abstract] [Full Text] [Related]

  • 3. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN, Bashir MM.
    J Coll Physicians Surg Pak; 2018 Jan 18; 28(1):40-43. PubMed ID: 29290190
    [Abstract] [Full Text] [Related]

  • 4. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
    Kang I, Siperstein R, Quan T, Breitenstein ML.
    Clin Rheumatol; 2004 Dec 18; 23(6):509-15. PubMed ID: 15801070
    [Abstract] [Full Text] [Related]

  • 5. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
    Sharmin S, Ahmed S, Abu Saleh A, Rahman F, Choudhury MR, Hassan MM.
    Bangladesh Med Res Counc Bull; 2014 Aug 18; 40(2):74-8. PubMed ID: 26415344
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC, Barcellos KS, Andrade LE.
    J Rheumatol; 2005 Jul 18; 32(7):1267-72. PubMed ID: 15996063
    [Abstract] [Full Text] [Related]

  • 9. Detection and identification of significant ANAs in previously determined ANA negative samples.
    Kidd K, Cusi K, Mueller R, Goodner M, Boyes B, Hoy E.
    Clin Lab; 2005 Jul 18; 51(9-10):517-21. PubMed ID: 16285474
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z, Ren Y, Liu D, Lin F, Liang Y.
    APMIS; 2016 Sep 18; 124(9):805-11. PubMed ID: 27328803
    [Abstract] [Full Text] [Related]

  • 11. The Frequency of Immunofluorescence Antinuclear Antibody Patterns and Extractable Nuclear Antigen: Experience From a Large Laboratory in Pakistan.
    Imran K, Loya A, Hameed M, Siddiqui IA, Sheikh UN.
    Cureus; 2023 Jan 18; 15(1):e33343. PubMed ID: 36751152
    [Abstract] [Full Text] [Related]

  • 12. Anti-ENA antibody profiles in patients with hepatitis C virus infection.
    Litwin CM, Rourk AR.
    J Clin Lab Anal; 2018 Mar 18; 32(3):. PubMed ID: 28605141
    [Abstract] [Full Text] [Related]

  • 13. Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus.
    Verdelli A, Coi A, Marzano AV, Antiga E, Cozzani E, Quaglino P, La Placa M, Benucci M, De Simone C, Papini M, Parodi A, Bianchi F, Caproni M.
    J Eur Acad Dermatol Venereol; 2019 Apr 18; 33(4):742-752. PubMed ID: 29924416
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
    Desplat-Jego S, Bardin N, Larida B, Sanmarco M.
    Ann N Y Acad Sci; 2007 Aug 18; 1109():245-55. PubMed ID: 17785313
    [Abstract] [Full Text] [Related]

  • 15. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
    Broadfoot A, Sivertsen T, Baumgart K.
    Pathology; 2016 Apr 18; 48(3):247-50. PubMed ID: 27020500
    [Abstract] [Full Text] [Related]

  • 16. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
    Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE.
    Arthritis Rheum; 2011 Jan 18; 63(1):191-200. PubMed ID: 20954189
    [Abstract] [Full Text] [Related]

  • 17. Association between antinuclear antibodies (ANA) patterns and extractable nuclear antigens (ENA) in HEp-2 cells in patients with autoimmune diseases in Riyadh, Saudi Arabia.
    Alsubki R, Tabassum H, Alfawaz H, Alaqil R, Aljaser F, Ansar S, Al Jurayyan A.
    Intractable Rare Dis Res; 2020 May 18; 9(2):89-94. PubMed ID: 32494555
    [Abstract] [Full Text] [Related]

  • 18. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
    Peene I, Meheus L, Veys EM, De Keyser F.
    Ann Rheum Dis; 2001 Dec 18; 60(12):1131-6. PubMed ID: 11709455
    [Abstract] [Full Text] [Related]

  • 19. From ANA to ENA: how to proceed?
    Damoiseaux JG, Tervaert JW.
    Autoimmun Rev; 2006 Jan 18; 5(1):10-7. PubMed ID: 16338206
    [Abstract] [Full Text] [Related]

  • 20. Antibodies to the extractable nuclear antigens (ENA) in Pakistani patients with systemic rheumatic disease.
    Ahmed TA, Malik IA, Saleem M, Khan AA, Hameed A, Shah ST, Amin SJ, Farooqi A.
    J Pak Med Assoc; 1995 Jan 18; 45(1):12-4. PubMed ID: 7731078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.